.
Molecularly imprinted polymers (MIPs) are artificial sorbents possessing high selectivity towards the target molecule present in multicomponent mixtures. The most common strategy in MIP preparation consists in using interactions between the target molecule (template, imprint) and some functional groups.
These interactions lead to the formation of the complexes between template and functional monomer in solution. During polymerization, target templates are mixed with functional monomers. After the formation of polymer, template molecules are extracted from polymer network. As a result, specific recognition cavities are formed [13, 14] .
There are two strategies for molecular imprinting; in the first method, template is bound with functional monomers by noncovalent interactions, and in the second one, covalent bonds are used [15, 16] . Nowadays, polymers imprinted with different templates like drugs, herbicides, sugars, nucleotides, amino acids and proteins are widely used in analytical science, as well as in catalysis and synthesis [17, 18] . Moreover, MIPs have a considerable potential for application in the areas of clinical analysis, medical diagnostics, environmental monitoring and drug delivery. MIPs are easy to prepare, stable, inexpensive and loading solution into column. The fractions were collected using an 1220 fraction collector (ISCO, USA).
Preparation and characterization of UA-MIPs.
The UA-MIPs were synthesized according to the standard procedure with a few modifications; the steps of the synthesis are listed below.
(a) Preparation of pre-assembly solution. UA was used as a template molecule and added to the copolymerization mixture, as well as soluble salts of UA and different organic bases (Table 1) .
capable of molecular recognition [19, 20] . We have developed a number of original methods of controlling sorption equilibrium and selectivity of sorption of biologically active target substances by polymeric sorbents [21] [22] [23] .
In this study, our principal objective was to synthesize a number of UA-MIPs. The second goal was to investigate the capability of UA-MIPs for the selective recognition of UA from model solutions. The selective sorption capacity of UA-MIP (an effective indicator of selective sorption) was established as the difference between sorption capacities of UA-MIP and non-imprinted polymers (NIP). The kinetics and dynamics of UA selective sorption were also investigated. Further, the selective recognition ability of the novel MIPs was evaluated using serum with high concentration of UA.
In the preparation of the novel MIPs, the following compounds were used: UA as a target molecule, DMAEMA as a functional monomer and EGDMA as a crosslinker. The corresponding NIPs were synthesized under the same synthesis conditions, but without UA.
Materials and methods

Materials and instruments
Chemically pure uric acid (2,6,8-trioxypurine) and xanthine Peritoneal liquid obtained from patients after dialysis was used as the solution which models serum composition most adequately. We have also used serum with high concentration of UA (more than 420 µmol/L), which was obtained from people with chronic renal failure and gout.
Single-component water solutions of UA (or xanthine) were used for studying the main sorption parameters. Since UA is low soluble in water, it was dissolved in solution of Li 2 CO 3 (0.3 g/L). Xanthine was dissolved in the 0.1 N solution of NaOH.
The optical density measurements were performed using an SPH-256 spectrophotometer (LOMO, Russia). The sorption dynamics experiments were carried out using laboratory columns of different sizes. An PP-1M pump (LOMO, Russia) was used for where DCPS is 3,5-dichloro-2-phenolsulfonate; ААP is 4-aminoantipyrine.
In the first stage, UA is oxidized by uricase with the formation of Н 2 О 2 . Then, Н 2 О 2 is oxidized by chromogens with the formation of dyed complex. The intensity of IR band at 520 nm is directly proportional to the concentration of uric acid in peritoneal liquid.
The concentration of UA was calculated using the equation:
where С is the concentration of UA in peritoneal liquid (µmol/L), Е tt is the IR absorption intensity at 520 nm in test tube, Е ct is the IR absorption intensity at 520 nm in control tube, 357 µmol/L is the concentration of UA in control tube.
The sorption capacity was calculated using the equation:
where С, С eq are the initial and equilibrium concentrations of UA, respectively (mmol·mL We have also determined the coefficient of distribution of UA (or xanthine) between mobile phase and stationary phase of sorbent as:
where Q e is the sorption capacity of sorbent for UA (mg/g), ρ s is the packing density (g/mL), К s is the swelling coefficient, C eq is the equilibrium concentration of UA (mmol·mL -1 ).
Thermodynamics of sorption
The free energy of sorption ΔG (J/mol) was calculated as:
Thus, UA was dissolved in diallylamine, ethylenediamine, diethylamine and guanidine.
(b) Preparation of pre-polymerization solution. UA salt (4 wt%) was added to 100 mL of glycerin and stirred for 15 min.
Then, the pre-assembly solution was added to the mixture of EGDMA (20 wt%) and DMAEMA (2 wt%) and stirred for 10 min to prepare the pre-polymerization solution.
(c) Polymerization. The pre-polymerization solution was poured into a three-necked round-bottomed flask, and 0.08 g of azobisisobutyronitrile (AIBN) was added. The mixture was stirred in N 2 atmosphere, while the temperature was increased up to 70°C.
The reaction was carried out at a temperature of 70°C for 2 h. (e) The corresponding non-imprinted polymers (NIPs) were prepared in a similar way to that described above, but without the addition of UA. NIPs were used as reference samples during characterization.
Then, sorbents were dried to constant weight. The sorbent particles with a size of 160-315 µm were obtained by grinding and sifting.
The swelling coefficient (К s ) was defined as a ratio between volumes of swollen and dry MIPs:
where V s is the volume of swollen sorbent (cm 
The average time of sorption was calculated as: (13) where: ρ is the relative "core radius", which is calculated by means of the following formula:
Thickness of the sorption layer (L) was determined experimentally as the average radius of sorbent particles which provides the maximum UA sorption capacity. 
Dynamics of uric acid sorption
The frontal dynamic sorption experiments were conducted on the laboratory columns: 30 mL of the UA model solution with the known initial concentration was loaded into the column with the studied sorbent. After sorption, the concentration of UA at the outlet of the column was determined spectrophotometrically by measuring optical density at 293 nm.
Elution curves, С = f (V), were obtained, where С is the concentration of UA in eluate (µmol/L); V is the elution volume (mL).
Results and discussion
3.1 Synthesis and design of MIPs. Selection of the best MIP.
The synthesis of new crosslinked polymers based on DMAEMA as a functional monomer and EGDMA as a crosslinker was studied. The study of the main physico-chemical and sorption
properties of the sorbents showed the influence of the DMAEMA hydrolysis activity on the formation of polyampholyte matrix of polymers. The composition of each MIP is shown in detail in Table 1 .
UA-MIP-1-0.08 are polyampholytes; they can absorb UA only from model aqueous solutions (Table 2) . These polymers were synthesized with the addition of 0.08 mol% of UA to the polymerization mixture.
To optimize the performance of introduced uric acid as a template molecule, UA was dissolved in different organic bases, which cannot act as monomers in the polymerization.
Thus, UA was dissolved in guanidine (16 mol% ΤΔЅ= ΔH -ΔG.
(8)
Sorption kinetics of uric acid
The experiments on kinetics of UA sorption were carried out as follows: 50 mL of model solution with the known content of UA was added into the bottle containing 50 mg of swollen sorbent.
In the course of experiment, during continuous stirring, samples (0.2 mL) were taken at defined intervals. Then, the concentration of UA in samples was determined from optical density of the UV absorption band at 293 nm with the use of calibration curve.
The kinetics of sorption of UA by UA-MIP-7-16 was investigated using two kinetic models: (a) the Boyd model and (b) the "shall and core" model [24] .
The Boyd model is commonly used for description of intraparticle diffusion mechanism of mass transfer. This model assumes homogeneous distribution of sorbate.
where is the diffusion coefficient, cm
; R is the radius of the swollen sorbent, µm; β is the slope of linear part of the
) dependence, where F is the degree of equilibrium reached at the time t.
The average time of sorption was calculated as:
In the case of intradiffusion kinetics: (11) According to "shell and core" model, kinetic parameters of sorption are calculated taking into account sorption of a substance in a limited layer of sorbent. (12) where L is the sorption layer, µm; t is the average time of diffusion.
Equilibrium sorption of UA from model solutions
To study the UA sorption specificity, we used two sorbents:
UA-MIP-7-16 and its NIP. The equilibrium sorption of UA and its closest structural analogue (xanthine) from model aqueous solutions and complex peritoneal liquid was studied.
First, adsorption experiments using the batch method were performed, and Figures 3 and 4 give the adsorption isotherms of NIP and UA-MIP-7-16 for UA and xanthine.
The isotherms in Figure 3 (a,b) show sorption of UA by UA-MIP-7-16 and NIP at different temperatures. The sorption of UA from model aqueous solution (with and without 0.9 % of NaCl) was studied in the wide range of UA concentrations.
The sorption capacity of UA-MIP-7-16 considerably exceeded the sorption capacity of NIP, especially when UA concentration was higher than 300 µmol/L. UA was able to interact with UA-MIP-7-16 and demonstrated both non-specific and specific binding (sorption in imprinted cavities). The character of UA sorption isotherms had a similar tendency in the case of UA-MIP-7-16 and NIP (Figure 3b ).
In the studies of sorption specificity, we also used the closest structural analogue of UA (xanthine) and model aqueous solutions with and without 0.9 % of NaCl. Xanthine (2,6-dihydroxypurine) is a precursor of UA in the purine Then, UA was dissolved in diallylamine, and UA-MIP-3-16 and UA-MIP-4-16 were synthesized. UA-MIP-3-16 is an anionic polymer, it can absorb UA only from the model aqueous solution. UA-MIP-4-16 is a polyampholyte, it can absorb UA both from model aqueous solutions and peritoneal liquid (10 mmol/g). The mass yields of these sorbents were low (<30%).
Modification of the synthesis conditions (excluding DMAEMA from the copolymerization mixture) also allows to improve biogenic properties of sorbents [26] . Thus, UA was dissolved in ethylenediamine (7 mol%) and diethylamine 
Effect of temperature on sorption equilibrium
To study the nature of intermolecular interactions between UA and complementary cavities, we need to understand the effects of temperature on the binding characteristics of UA-MIP-7-16. biosynthesis. The xanthine sorption capacity of UA-MIP-7-16
and NIP does not change over the wide range of concentrations.
Moreover, the xanthine sorption capacity of NIP was higher than that of UA-MIP-7-16. Therefore, both xanthine and UA take part in the same non-specific interactions with polymeric sorbent matrix.
To understand the nature of intermolecular interactions, the main thermodynamic functions were calculated using the model solutions of UA and xanthine. 
Kinetics of uric acid sorption
The study of sorption kinetics allowed us to determine the mechanism of diffusion of sorbate into sorbent phase and the influence of sorption medium and physicochemical factors on the diffusion flow. The experimental data were interpreted using kinetic curves F=f( t ), (Figure 5 The main kinetic parameters are presented in Table 4 .
The diffusion coefficients and average sorption times were 
This work is supported by the Russian Foundation for Basic
Research (Grant № 09-03-00516-а).
(NRCERM, EMERCOM of Russia) and the Saint-Petersburg I. I.
Mechnikov State Medical Academy for aid in research.
[1] Richette P., Bardin T., Gout, The Lancet, 2010, 375, 318-328.
[2] Smith E.U.R., Diaz-Torne C., Perez-Ruiz F., March L.M., 
